carvedilol has been researched along with Pulmonary Embolism in 3 studies
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Evlakhov, I | 1 |
| Poyassov, IZ | 1 |
| Ovsyannikov, VI | 1 |
| Vasanthakumar, N | 1 |
| Severino, M | 1 |
| Giacomini, T | 1 |
| Verrina, E | 1 |
| Prato, G | 1 |
| Rossi, A | 1 |
3 other studies available for carvedilol and Pulmonary Embolism
| Article | Year |
|---|---|
Changes in Pulmonary Circulation in Experimental Model of Pulmonary Thromboembolism after Carvedilol Treatment.
Topics: Animals; Carvedilol; Lung; Pulmonary Circulation; Pulmonary Embolism; Pulmonary Veins; Rabbits | 2019 |
Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme 2; Betacoronavirus; Carvedilol; Coronavir | 2020 |
Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno-osseous dysplasia.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Carvedilol; Child; Clopidogrel; Diagnosis, Differential; | 2018 |